Search results for: 'denali on defend'
- Did you mean
- deal on defend
- Related search terms
- denali+on+defend
- denali+cultur+sciences+2017
- denali cultur sciences 2017
- denali+captor+servic+2004
- denali captor servic 2004
-
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025September 2025$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025September 2025$4,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Licensing Deals in Biotechnology 2019-2025September 2025$4,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Collaboration Deals in Biotechnology 2020-2025September 2025$4,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More
